Global Glycomics Glycobiology Market Overview
Glycomics is a field of glycobiology and aims to detect the structure and function of the complete set of glycans produced in a given cell or organism and identify all the genes that encode glycoproteins. The tools of glycomics are utilized for various clinical applications for disease diagnosis, detection of cancer, and personalized medicine. Its nanomaterials are also used as vaccine against viral and bacterial infections and cancer cells. Glycobiology is a fastly evaluating area of interest in the field of biotechnology, biomedicine, and basic research. Glycobiology deals with the study of the structure, function and biology of carbohydrates, also called as glycans. Glycans are present in every living organism. In eukaryotic cells, most proteins are modified post-translationally. Glycosylation or Glycans attachment is one of the most common cell viability modifications. There are two methods of glycosylation: N-linked (glycan attached to asparagine) and O-linked (glycan attached to serine or threonine). The global glycomics market accounted for US$ 1.78 billion in 2020 and is estimated to be US$ 6.90 billion by 2030 and is anticipated to register a CAGR of 14.7%.
Global Glycomics Glycobiology Market Dynamics
Biotech companies are leading to rise in R&D investments due to growth in their drug discovery and development. Further, increasing the number of initiatives undertaken by the government to upsurge funding for R&D has resulted to the increased need for glycomics techniques. The Australian government invested approximately US$ 10.4 billion for scientific research innovations and activities for the period 2017-2018. In 2015, the Irish Government also invested US$ 5.6 billion spending on research, which was intended to grow the number of scientific research activities from 25,000 to 40,000. Hence, the necessity for glycomics research techniques for leading comprehensive glycomes study is continuously increasing.
Enzymes are projected to estimate for a significant market share over the forecast period due to growing research in cancer therapeutics and diagnosis. Glycomics deals with several research methods to define or quantify glycome of a tissue, cell, or organism. Key players are also undertaking extensive R&D initiatives to develop technologically advanced and new products. For instance, in 2016, ProZyme, Inc. developed Gly-Q Glycan Analysis System, and combined platform that provides high-throughput and user-friendly glycoanalysis.
However, stringent regulatory frameworks and high degree of consolidation may limit the growth of the global market over the forecast period.
Global Glycomics Glycobiology Market Segmentation
The global glycomics market is segmented based on product type, application, end-user, and region.
On the basis of product type, the global glycomics/glycobiology market is segmented into enzymes, kits, reagents, and instruments. Based on application, the target market is segmented into drug discovery & development, diagnostics, and others. On the basis of end-user, the global market is classified into academic & research institutes, pharmaceutical & biotechnology companies, and CROs.
Regional Insights:
The global glycomics market accounted for US$ 1.78 billion in 2020 and is estimated to be US$ 6.90 billion by 2030 and is anticipated to register a CAGR of 14.7%. On region the global glycomics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America estimated for the highest market share in 2018 owing to the presence of major pharmaceutical and biopharmaceutical companies including Agilent Technologies, Merck KGaA, Danaher, and Thermo Fisher Scientific. Accessibility to advanced products and presence of well-established healthcare infrastructure have driven the regional market growth. Furthermore, government funding for R&D activities is another key factor propelling the global Glycomics/Glycobiology market growth in this region. Asia Pacific is projected to be the second fastest-growing regional market due to untapped market opportunities during the forecast period.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Billion & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Product type- Enzymes, kits, Reagents, and Instruments
By Application– Drug Discovery & Development, Diagnostics, and Others
By End-user– Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and CROs
|
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global glycomics market report based on product type, application, end-user, and region.
Global Glycomics Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Glycomics Glycobiology Market Key Players
The key players operating the global glycomics/glycobiology market includes Agilent Technologies, Thermo Fisher Scientific, Inc., Merck KGaA, New England Biolabs, Danaher, Shimadzu Corporation, Bruker, Takara Bio, Inc, and ProZyme. Most of these key players have an extensive product portfolio along with strong regional presence. For instance, in 2018, Shimadzu Corporation collaborated with PREMIER Biosoft, an innovative company in the field of bioinformatics solutions. The collaboration was aimed introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis. New mergers and acquisitions, product launches, collaborations, and partnerships are the key strategies undertaken by these companies for sustainable growth.
Global Glycomics Glycobiology Market Company Profile
- Agilent Technologies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- New England Biolabs
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Danaher
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Shimadzu Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bruker
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Takara Bio, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- ProZyme
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Glycomics Glycobiology Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Glycomics/Glycobiology Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End-user
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Glycomics/Glycobiology Market, By Product Type, 2018 – 2026, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 – 2026
- Y-o-Y Growth Analysis (%), 2018 – 2026
- Segment Trends
- Enzymes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Glycosidases
- Neuraminidases
- Glycosyltransferases
- Sialyltransferases
- Others
- Kits
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Glycan Labeling Kits
- Glycan Purification Kits
- Glycan Release Kits
- Others
- Reagents
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Glycoproteins
- Monosaccharides
- Oligosaccharides
- Others
- Instruments
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Mass Spectrometers
- HPLC
- MALDI-TOF
- Array Systems
- Others
- Overview
- Global Glycomics/Glycobiology Market, By Application, 2018 – 2026, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 – 2026
- Y-o-Y Growth Analysis (%), 2018 – 2026
- Segment Trends
- Drug Discovery & Development
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Diagnostics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Overview
- Global Glycomics/Glycobiology Market, By End-user, 2018 – 2026, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 – 2026
- Y-o-Y Growth Analysis (%), 2018 – 2026
- Segment Trends
- Academic & Research Institutes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- CRO’s
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Overview
- Global Glycomics/Glycobiology Market, By Region, 2018 – 2026, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 – 2026
- Y-o-Y Growth Analysis (%), 2018 – 2026
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By End-user, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By End-user, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By End-user, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By End-user, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By End-user, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Agilent Technologies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- New England Biolabs
- Danaher
- Shimadzu Corporation
- Bruker
- Takara Bio, Inc.
- ProZyme
- Agilent Technologies
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Global Glycomics/Glycobiology Market is valued at US$1.0 billion in 2020
The Global Glycomics/Glycobiology Market is projected to increase at a CAGR of 14.8% during the forecast period.
The global glycomics/glycobiology market is segmented based on product type, application, end-user, and region.
Increasing R&D expenditure and growing funding for proteomics and glycomics research
North America estimated for the highest market share in 2018 owing to the presence of major pharmaceutical and biopharmaceutical companies including Agilent Technologies, Merck KGaA, Danaher, and Thermo Fisher Scientific.
Most of these key players have an extensive product portfolio along with strong regional presence. For instance, in 2018, Shimadzu Corporation collaborated with PREMIER Biosoft, an innovative company in the field of bioinformatics solutions.